Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Acta Med Port ; 36(10): 618-630, 2023 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-37643476

RESUMO

INTRODUCTION: The COVID-19 pandemic has presented numerous challenges to healthcare systems. As the number of affected individuals continues to rise, it is crucial to find preventive, diagnostic, and therapeutic approaches. This study aims to describe different COVID-19 sequelae within a Primary Health Care population. METHODS: A retrospective cohort study was conducted in adults diagnosed with COVID-19 from March 2020 to April 2022, excluding pregnant women, minors, nursing home residents, hospitalizations, and deaths. Data was gathered from surveillance records on the Trace COVID-19® platform, a pre-set original questionnaire (which included the Portuguese version of the World Health Organization's Quality of Life Assessment Instrument), and, if needed, patient electronic health records. Information on sociodemographic and clinical characteristics of acute COVID-19 was collected along with long COVID symptoms. RESULTS: This study included 284 patients, aged 19 to 99 years old. The five most prevalent acute COVID-19 symptoms were fever (50.0%), tiredness (48.2%), myalgias (44.7%), dry cough (37.7%) and odynophagia (36.3%). Symptoms related to the neurological system (23.2%) and tiredness (22.9%) were the most prevalent in long COVID symptoms. Acute tiredness and arthralgia were associated with all long COVID outcomes. The associations between acute COVID-19 symptoms with long COVID outcomes were stronger for anosmia [OR = 5.07, 95% confidence interval (CI) 2.49 - 10.36, p < 0.001] on a neurological chapter, acute tiredness for long lasting tiredness (OR = 4.07, 95% CI 2.07 - 8.02, p = 0.041), fatigue for muscles and/or bones chapter (OR = 7.55, 95% CI 3.06 - 18.66, p < 0.001), tiredness on an endocrine/hormonal chapter (OR = 6.54, 95% CI 2.37 - 18.04, p < 0.001), dyspnea for respiratory symptoms (OR = 5.67, 95% CI 1.92 - 16.74, p = 0.002) and fever for stomach or intestine symptoms (OR = 8.06, 95% CI 2.55 - 25.47, p < 0.001). Almost all quality of life dimensions were negatively associated with the number of long COVID symptoms. CONCLUSION: A higher number of acute symptoms, as well as the presence of specific COVID-19 symptoms were associated with reported symptoms ≥ 12 weeks after infection. In the studied population, an increased number of symptoms in both acute and long COVID had a significant negative impact on the perception of overall quality of life. The identification of these relationships could provide a new perspective for post-COVID care.


Assuntos
COVID-19 , Síndrome de COVID-19 Pós-Aguda , Gravidez , Adulto , Humanos , Feminino , Adulto Jovem , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , COVID-19/epidemiologia , Estudos Retrospectivos , Pandemias , Qualidade de Vida , Febre
2.
RMD Open ; 4(Suppl 1): e000785, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30402272

RESUMO

Antiphospholipid syndrome (APS) is a rare disease characterised by venous and/or arterial thrombosis, pregnancy complications and the presence of specific autoantibodies called antiphospholipid antibodies. This review aims to identify existing clinical practice guidelines (CPG) as part of the ERN ReCONNET project, aimed at evaluating existing CPGs or recommendations in rare and complex diseases. Seventeen papers providing important data were identified; however, the literature search highlighted the scarceness of reliable clinical data to develop CPGs. With no formal clinical guidelines in place, diagnosis and treatment of APS is largely based on consensus and expert opinion. Patients' unmet need refers to the understanding of the disease and its clinical picture and implications, the need of education for patients, family members and healthcare providers, as well as to the development of monitoring pathways involving multiple healthcare providers.

3.
Clin Case Rep ; 5(12): 2066-2070, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-29225858

RESUMO

Primary immunodeficiency disorders are rarely diagnosed in adults but must be considered in the differential diagnosis of combined recurrent infections and autoimmune disease. We describe a patient with CTLA-4 haploinsufficiency and an abnormal regulatory T-cell phenotype. Unusually, infections were more severe than autoimmunity, illustrating therapeutic challenges in disease course.

4.
Rev. Soc. Bras. Clín. Méd ; 15(1): 46-49, 2017.
Artigo em Português | LILACS | ID: biblio-833142

RESUMO

O carcinoma de células renais, em particular o tipo cromófobo, é uma patologia rara na idade fértil, o que explica a pouca informação disponível na literatura. Os autores apresentam o caso de uma mulher de 37 anos, multípara, com hipertensão arterial de novo, de difícil controle e hematúria às 10 semanas de gravidez, tendo o estudo etiológico do quadro hipertensivo demostrado a existência de um tumor renal. Às 17 semanas de gravidez, a doente foi submetida à nefrectomia esquerda, tendo a cirurgia decorrido sem intercorrências. A histologia demostrou tratar-se de um carcinoma do subtipo cromófobo. O restante da gravidez decorreu sem complicações, com perfil tensional controlado, com um parto vaginal de termo com um recém-nascido saudável.


Renal cell carcinoma, particularly the chromophobe type, is a rare pathology in childbearing age, and consequently, in literature, few cases during pregnancy have been reported. The authors present the case of a 37-year-old, multiparous woman, with de novo high blood pressure of difficult control, and hematuria at 10-week gestation. The etiological study of the hypertensive disorder has demonstrated the existence of a renal tumor. The patient underwent left radical nephrectomy at 17-week gestation. Histology was compatible with chromophobe subtype renal cell carcinoma. The remaining pregnancy period progressed with no complications, with controlled tension profile, and resulted in spontaneous vaginal delivery of a healthy infant at term.


Assuntos
Humanos , Feminino , Gravidez , Adulto , Hipertensão/complicações , Neoplasias Renais/diagnóstico , Neoplasias Renais/cirurgia , Complicações Neoplásicas na Gravidez/diagnóstico , Diagnóstico Diferencial , Ultrassonografia/métodos
5.
Case Rep Neurol ; 8(1): 59-65, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27065427

RESUMO

Progressive multifocal leukoencephalopathy (PML) caused by reactivation of the JC virus (JCV), a human polyomavirus, occurs in autoimmune disorders, most frequently in systemic lupus erythematosus (SLE). We describe a HIV-negative 34-year-old female with SLE who had been treated with immunosuppressant therapy (IST; steroids and azathioprine) since 2004. In 2011, she developed decreased sensation and weakness of the right hand, followed by vertigo and gait instability. The diagnosis of PML was made on the basis of brain MRI findings (posterior fossa lesions) and JCV isolation from the cerebrospinal fluid (700 copies/ml). IST was immediately discontinued. Cidofovir, mirtazapine, mefloquine and cycles of cytarabine were sequentially added, but there was progressive deterioration with a fatal outcome 1 year after disease onset. This report discusses current therapeutic choices for PML and the importance of early infection screening when SLE patients present with neurological symptoms. In the light of recent reports of PML in SLE patients treated with rituximab or belimumab, we highlight that other IST may just as well be implicated. We conclude that severe lymphopenia was most likely responsible for JCV reactivation in this patient and discuss how effective management of lymphopenia in SLE and PML therapy remains an unmet need.

6.
BMJ Case Rep ; 20122012 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-22605591

RESUMO

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder that is characterised by the presence of antiphospholipid antibodies and a common cause of vascular thromboembolic phenomena. The management of patients with APS is currently directed to antithrombotic medications. The international therapeutic guidelines recommend oral anticoagulation with warfarin indefinitely after the first thrombotic episode. However, therapeutic guidelines lack for a minority group of patients - the patients appropriately anticoagulated with recurrent thromboembolic phenomena. The authors present a clinical report that reveals the therapeutic and diagnostic complexity of this specific group of patients. Regarding recent studies, APS has been revealed as a complex syndrome with multiple pathophysiological mechanisms previously unknown. In this context, new therapeutic approaches have been defended and empirically experienced, with potentially promising results.


Assuntos
Síndrome Antifosfolipídica/complicações , Embolia Pulmonar/diagnóstico , Embolia Pulmonar/etiologia , Trombose/diagnóstico , Trombose/etiologia , Anticorpos Antifosfolipídeos/análise , Broncoscopia , Diagnóstico Diferencial , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...